| 期 |
栏目 |
标题 |
文件 |
| 卷 79, 编号 6 (2004) |
Editorial |
Cardiorenai interactions: ciinicai indications and roie in pathogenesis of cardiovascular and renal diseases |
|
| 卷 81, 编号 10 (2009) |
Editorial |
Essential hypertension, dementia, and antihypertensive therapy in geriatric patients |
|
| 卷 83, 编号 12 (2011) |
Editorial |
Cardiorenal syndromes: pathogenetic, clinicodiagnostic, prognostic and therapeutic aspects |
|
| 卷 83, 编号 12 (2011) |
Editorial |
Efficacy of ivabradin in combined treatment of patients with postinfarction systolic chronic cardiac failure |
|
| 卷 85, 编号 4 (2013) |
Editorial |
A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris |
|
| 卷 86, 编号 6 (2014) |
Editorial |
Biomarkers of acute kidney injury: Current views and prospects |
|
| 卷 87, 编号 2 (2015) |
Editorial |
Hypertensive patients' adherence, motivation, and awareness during fixed-dose perindopril A and amlodipine combination treatment (Results of the CONSTANTA trial) |
|
| 卷 87, 编号 3 (2015) |
Editorial |
Optimization of treatment in hypertensive patients in real clinical practice: Role of a fixed-dose perindopril A and amlodipine combination (Results of the Russian observational CONSTANTA trial) |
|
| 卷 87, 编号 6 (2015) |
Editorial |
Contrast-induced acute kidney injury after primary percutaneous coronary interventions: Prevalence, predictive factors, and outcomes |
|
| 卷 87, 编号 8 (2015) |
Editorial |
Clinical pharmacology and pharmacotherapy: Problems and disputable issues |
|
| 卷 88, 编号 6 (2016) |
Editorial |
The concurrence of kidney and liver dysfunctions in decompensated heart failure |
(Rus)
|
| 卷 89, 编号 12 (2017) |
Editorial |
Alirocoumab: new perspectives of lipid-lowering therapy |
|
